Stock market today: S&P 500 closes at fresh record ahead of Nvidia earnings
SALT LAKE CITY - Utah Medical Products, Inc. (NASDAQ:UTMD) announced Tuesday its Board of Directors has approved a quarterly cash dividend of $0.305 per share of common stock, representing a 1.7% increase from the same quarter last year. The company has maintained dividend payments for 22 consecutive years, with the current yield standing at 2.11%.
The dividend will be payable on October 2, 2025, to stockholders of record at the close of business on September 17, 2025. According to InvestingPro, UTMD maintains a strong financial health score of "GREAT" and holds more cash than debt on its balance sheet.
Utah Medical Products specializes in healthcare products for women and their babies, developing and manufacturing specialty medical devices that are used by clinicians globally.
The company’s announcement came through a press release statement issued today.
In other recent news, Utah Medical Products announced a 1.7% increase in its quarterly cash dividend, raising it to $0.305 per share. This adjustment will benefit stockholders who are on record by June 16, 2025, with the dividend payment scheduled for July 3, 2025. This development marks a continuation of the company’s commitment to returning value to its shareholders. The announcement highlights the company’s financial stability and its ability to consistently generate cash flow. Investors may view this increase as a positive signal regarding the company’s financial health. The dividend boost is part of Utah Medical Products’ ongoing strategy to enhance shareholder value. This recent development is noteworthy for those following the company’s financial performance and shareholder policies.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.